Bioscience

BIO5 Oro Valley, TGen collaborate on Alzheimer’s

April 12, 2013

By Flinn Foundation

From: AZ Business Magazine

BIO5 Oro Valley and Translational Genomics Research Institute announced a collaboration in March to develop new therapies for the treatment of Alzheimer’s and other neurodegenerative diseases.  Statistics from the National Institutes of Health indicate that 5.1 million older Americans – or one in eight – suffer from Alzheimer’s, the sixth-leading cause of death in the United States.

Read More: BIO5-TGen collaboration targets Alzheimer’s disease